Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study (Q35012174)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study |
scientific article |
Statements
1 reference
Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study (English)
1 reference
Naomi Schlesinger
1 reference
Eduardo Mysler
1 reference
Hsiao-Yi Lin
1 reference
Marc De Meulemeester
1 reference
Jozef Rovensky
1 reference
Udayasankar Arulmani
1 reference
Alison Balfour
1 reference
Gerhard Krammer
1 reference
Peter Sallstig
1 reference
Alexander So
1 reference
3 May 2011
1 reference
1 reference
70
1 reference
7
1 reference
1264-1271
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference